认知刺激疗法:为经历痴呆症的密苏里州老年人做出改变
Ebow Tawiah Nketsiah1, Marla Berg-Weger2, Max Zubatsky3
1PhD Candidate, Saint Louis University School of Social Work, St. Louis, Missouri.
Missouri medicine
|April 28, 2025
概括
认知刺激疗法 (CST) 改善了痴呆症患者的认知功能,情绪和生活质量. 这种非药物治疗为记忆,语言和情绪健康提供了可获得的好处.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 痴呆症和阿尔茨海默氏症是一个重大的公共卫生挑战,特别是在密苏里州.
- 目前的治疗方法往往严重依赖于药理干预措施,这些干预措施可能无法解决患者福祉的所有方面.
- 越来越需要基于证据的非药物治疗方法来治疗痴呆症.
研究的目的:
- 告知医疗保健专业人员认知刺激疗法 (CST) 的好处和实际应用.
- 突出CST作为一种有效的干预措施,以提高痴呆症患者的认知功能,生活质量和情绪健康.
- 强调CST在解决痴呆症患者的认知,情感和社会需求方面的重要性.
主要方法:
- 本文回顾了认知刺激疗法 (CST) 的现有证据和实际应用.
- 它综合了关于CST对各种认知和情绪领域的影响的研究结果.
- 该审查审查了CST在不同护理环境中的适应性和实施情况.
主要成果:
- 认知刺激疗法 (CST) 在记忆,语言和执行功能方面显著改善.
- CST有效地减轻与痴呆相关的抑郁和焦虑症状.
- 该疗法提高了痴呆症患者的整体生活质量和情感福祉.
结论:
- 认知刺激疗法 (CST) 是一种有价值的,基于证据的,用于痴呆症护理的非药物干预.
- CST的适应性使得它可以在各种环境中使用,包括社区中心,住宅和虚拟平台.
- 将CST纳入临床实践对于改善痴呆患者的治疗结果和减少医疗保健系统负担至关重要.
相关概念视频
Cognitive Development During Adulthood
22
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
22
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Dementia
64
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
64
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315
Specialized Care Centers and Settings-II
676
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
676
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85


